Conquering Menopause and Perimenopause Weight Gain Perhaps the most challenging period for weight control is the transition into menopause
Last year brought clinical readouts demonstrating the GLP-1 drug class may be useful for a variety of conditions beyond obesity and diabetes, including heart failure, MASH, sleep apnea and chronic kidney disease
Penn researchers analyzed patient data and health outcomes for 111,646 women who were 45 to 80 years old and had body mass indexes of 25 or higher
These adaptations persist for years, possibly permanently, after weight loss
Victoza was superior in reducing A1C from baseline versus placebo at 26 weeks 1 Average adjusted A1C reductions a Victoza + MET basal insulin + MET basal insulin ELLIPSE From mean baseline A1C: 7.7% to 7.9% The change from baseline to end-of-treatment visit in A1C was analyzed using a pattern mixture model with multiple imputation
Essential Role of CD8 Palmitoylation in CD8 Coreceptor Function